ARTICLE | Company News
Serono amends Rebif BLA
October 8, 2001 7:00 AM UTC
Serono (SRA; SWX:SEO) submitted an amendment to its BLA for Rebif recombinant interferon beta-1a to treat relapsing-remitting multiple sclerosis (RRMS). SRA said the amendment includes clinical data f...